ASX - By Stock
|
AVR |
Re:
PCR London Valves
|
|
Danagram
|
122 |
58K |
5 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
122
|
58K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Why Admedus’ shift to aortic valve replacement is good news for patients under 65
|
|
Danagram
|
42 |
21K |
9 |
28/10/19 |
28/10/19 |
ASX - By Stock
|
42
|
21K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Danagram
|
63 |
39K |
13 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
63
|
39K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Frazer HPV vaccine progress
|
|
Danagram
|
4 |
2.2K |
1 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
4
|
2.2K
|
1
|
|
ASX - By Stock
|
AVR |
Frazer HPV vaccine progress
|
|
Danagram
|
4 |
2.2K |
3 |
22/05/19 |
22/05/19 |
ASX - By Stock
|
4
|
2.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 2019 AGM Presentation
|
|
Danagram
|
97 |
43K |
1 |
16/05/19 |
16/05/19 |
ASX - By Stock
|
97
|
43K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 2019 AGM Presentation
|
|
Danagram
|
97 |
43K |
0 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
97
|
43K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 2019 AGM Presentation
|
|
Danagram
|
97 |
43K |
2 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
97
|
43K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 2019 AGM Presentation
|
|
Danagram
|
97 |
43K |
28 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
97
|
43K
|
28
|
|
ASX - By Stock
|
AVR |
Re:
AGM day
|
|
Danagram
|
9 |
3.4K |
5 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
9
|
3.4K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AGM day
|
|
Danagram
|
9 |
3.4K |
9 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
9
|
3.4K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Facility Agreement with SIO Partners LP
|
|
Danagram
|
94 |
31K |
2 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
94
|
31K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Facility Agreement with SIO Partners LP
|
|
Danagram
|
94 |
31K |
11 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
94
|
31K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Danagram
|
64 |
25K |
6 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
64
|
25K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
Danagram
|
240 |
81K |
2 |
27/04/19 |
27/04/19 |
ASX - By Stock
|
240
|
81K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Danagram
|
152 |
54K |
0 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
152
|
54K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Danagram
|
170 |
66K |
2 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
170
|
66K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Danagram
|
170 |
66K |
0 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
170
|
66K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Transaction Terminated and Subsidiary Appoints Administrator
|
|
Danagram
|
52 |
25K |
4 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
52
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
New WP interview
|
|
Danagram
|
10 |
57K |
6 |
19/03/19 |
19/03/19 |
ASX - By Stock
|
10
|
57K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
|
|
Danagram
|
567 |
355K |
9 |
18/03/19 |
18/03/19 |
ASX - By Stock
|
567
|
355K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Class action
|
|
Danagram
|
240 |
81K |
0 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
240
|
81K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 3B
|
|
Danagram
|
72 |
26K |
3 |
05/03/19 |
05/03/19 |
ASX - By Stock
|
72
|
26K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Response to ASX Appendix 4C Query
|
|
Danagram
|
73 |
33K |
13 |
23/02/19 |
23/02/19 |
ASX - By Stock
|
73
|
33K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Response to ASX Appendix 4C Query
|
|
Danagram
|
73 |
33K |
8 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
73
|
33K
|
8
|
|
ASX - By Stock
|
MVP |
Re:
Ann: FY19 Half Year Report and Accounts
|
|
Danagram
|
41 |
15K |
4 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
41
|
15K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
CSIRO tweet
|
|
Danagram
|
23 |
11K |
1 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
23
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
CSIRO tweet
|
|
Danagram
|
23 |
11K |
5 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
23
|
11K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
CSIRO tweet
|
|
Danagram
|
23 |
11K |
0 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
23
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Chief Medical Officer Appointment
|
|
Danagram
|
28 |
11K |
11 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
28
|
11K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
AHZRA
|
|
Danagram
|
37 |
13K |
3 |
05/12/18 |
05/12/18 |
ASX - By Stock
|
37
|
13K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AHZRA
|
|
Danagram
|
37 |
13K |
1 |
05/12/18 |
05/12/18 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AHZRA
|
|
Danagram
|
37 |
13K |
4 |
05/12/18 |
05/12/18 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus launches rights issue
|
|
Danagram
|
250 |
85K |
3 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
250
|
85K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Response received from Wayne on LinkedIn
|
|
Danagram
|
140 |
51K |
8 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
140
|
51K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Response received from Wayne on LinkedIn
|
|
Danagram
|
140 |
51K |
2 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
140
|
51K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder
|
|
Danagram
|
81 |
43K |
14 |
18/09/18 |
18/09/18 |
ASX - By Stock
|
81
|
43K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Secures Strategic Investor
|
|
Danagram
|
390 |
156K |
29 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
390
|
156K
|
29
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Secures Strategic Investor
|
|
Danagram
|
390 |
156K |
14 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
390
|
156K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension of Voluntary Suspension
|
|
Danagram
|
125 |
54K |
1 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
125
|
54K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension of Voluntary Suspension
|
|
Danagram
|
125 |
54K |
2 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
125
|
54K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension of Voluntary Suspension
|
|
Danagram
|
125 |
54K |
9 |
20/08/18 |
20/08/18 |
ASX - By Stock
|
125
|
54K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
2018 a killer year says Wayne
|
|
Danagram
|
65 |
20K |
0 |
14/08/18 |
14/08/18 |
ASX - By Stock
|
65
|
20K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
2018 a killer year says Wayne
|
|
Danagram
|
65 |
20K |
17 |
14/08/18 |
14/08/18 |
ASX - By Stock
|
65
|
20K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Distribution agreement renewed for infusion supply chain
|
|
Danagram
|
38 |
20K |
21 |
09/08/18 |
09/08/18 |
ASX - By Stock
|
38
|
20K
|
21
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Voluntary Suspension
|
|
Danagram
|
155 |
58K |
0 |
07/08/18 |
07/08/18 |
ASX - By Stock
|
155
|
58K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Voluntary Suspension
|
|
Danagram
|
155 |
58K |
2 |
07/08/18 |
07/08/18 |
ASX - By Stock
|
155
|
58K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Danagram
|
144 |
56K |
2 |
06/06/18 |
06/06/18 |
ASX - By Stock
|
144
|
56K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Share Purchase Plan Results
|
|
Danagram
|
111 |
34K |
10 |
05/06/18 |
05/06/18 |
ASX - By Stock
|
111
|
34K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus secures further funding with Placement and SPP
|
|
Danagram
|
51 |
12K |
0 |
10/05/18 |
10/05/18 |
ASX - By Stock
|
51
|
12K
|
0
|
|